S. Mori

Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer

K. Shirouzu, Y. Ogata, Y. Akagi, 2009, Journal of surgical oncology.

Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal carcinoma.

K. Shirouzu, Y. Ogata, K. Matono, 2007, Anticancer research.

The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.

K. Shirouzu, Y. Ogata, K. Matono, 2006, Oncology reports.

Efficacy of the combined use of bevacizumab and irinotecan as a postoperative adjuvant chemotherapy in colon carcinoma.

K. Shirouzu, Y. Ogata, Y. Akagi, 2008, Oncology reports.

Biological features of sporadic colorectal carcinoma with high-frequency microsatellite instability: special reference to tumor proliferation and apoptosis

K. Shirouzu, Y. Ogata, S. Mori, 2004, International Journal of Clinical Oncology.

Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high risk to recurrence.

K. Shirouzu, Y. Ogata, Y. Akagi, 2007, Journal of experimental & clinical cancer research : CR.

A Familial Occurrence of Crohn's Disease and Ulcerative Colitis

K. Shirouzu, Y. Ogata, Y. Akagi, 2000 .

Intraoperative thermal ablation therapy for small colorectal metastases to the liver.

K. Shirouzu, Y. Ogata, Y. Akagi, 2008, Hepato-gastroenterology.

Dosage escalation study of S-1 and irinotecan in metronomic chemotherapy against advanced colorectal cancer.

K. Shirouzu, Y. Ogata, Y. Akagi, 2009, The Kurume medical journal.